Cadence Neuroscience
PrivateLast Round
Series B
May 17, 2023
Total Funding Raised
$41M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Cadence Neuroscience is a medical technology company that develops implantable neuromodulation therapy devices to treat drug-resistant epilepsy.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cadence Neuroscience Comparables
Compare Cadence Neuroscience with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Precisis GmbH | 82% | |
| Synergia Medical | 81% | |
| NeuroPace | 79% |
Cadence Neuroscience Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | May 17, 2023 | ||||
| Series A | Nov 6, 2019 |
Cadence Neuroscience Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| F-Prime Capital | Series B |
| JAZZ Venture Partners | Series B, Series A |
| Epilepsy Foundation | Series A |
| Mayo Clinic Ventures | Series A |
| Angelini Ventures | Series B |
| F-Prime Capital | Series B |
| Lumira Ventures | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 141% MoM, reaching 3.1K.
- Apr 19, 2026
Monthly visitors increased 33% MoM.
Recent news
Latest coverage and updates
- hiresSep 22, 2026
Cadence Neuroscience, Inc. hired Kent Leyde as Chief Technology Officer on Sep 22nd '26.
- hiresSep 22, 2026
Cadence Neuroscience, Inc. hired Chris Cronin as Chief Executive Officer on Sep 22nd '26.
Cadence Neuroscience Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Cadence Neuroscience's valuation, stock price, and market status.
Is Cadence Neuroscience a public or private company?
Cadence Neuroscience is a private company.
What is the current stock price of Cadence Neuroscience?
Cadence Neuroscience is a private company with no public stock price. No recent secondary market data is available.
How much is Cadence Neuroscience worth (valuation)?
Valuation information for Cadence Neuroscience is not publicly available.
Can I buy Cadence Neuroscience stock?
Cadence Neuroscience shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Cadence Neuroscience's last funding round?
Cadence Neuroscience's most recent funding round was Series B on May 17, 2023.
Who are the main investors in Cadence Neuroscience?
Key investors in Cadence Neuroscience include JAZZ Venture Partners.
Will Cadence Neuroscience IPO soon?
No public IPO plans have been announced for Cadence Neuroscience.
How can I track Cadence Neuroscience secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Cadence Neuroscience's secondary market activity and sign up for updates.